126
Views
1
CrossRef citations to date
0
Altmetric
Editorial

New insights on fibrosis in Crohn’s disease

, , , &
Pages 497-499 | Published online: 10 Jan 2014

References

  • Bernstein CN, Loftus EV Jr, Ng SC, Lakatos PL, Moum B; Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD). Hospitalisations and surgery in Crohn’s disease. Gut 61(4), 622–629 (2012).
  • Bailey JR, Bland PW, Tarlton JF et al. IL-13 promotes collagen accumulation in Crohn’s disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells? PLoS ONE 7(12), e52332 (2012).
  • Burke JP, Mulsow JJ, O’Keane C, Docherty NG, Watson RW, O’Connell PR. Fibrogenesis in Crohn’s disease. Am. J. Gastroenterol. 102(2), 439–448 (2007).
  • Speca S, Giusti I, Rieder F, Latella G. Cellular and molecular mechanisms of intestinal fibrosis. World J. Gastroenterol. 18(28), 3635–3661 (2012).
  • Rieder F, Kessler SP, West GA et al. Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis. Am. J. Pathol. 179(5), 2660–2673 (2011).
  • Son A, Oshio T, Kawamura YI et al. TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice. Mucosal Immunol. (2013).
  • Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat. Med. 12(1), 99–106 (2006).
  • Scharl M, Frei S, Pesch T et al. Interleukin-13 and transforming growth factor ß synergise in the pathogenesis of human intestinal fistulae. Gut 62(1), 63–72 (2013).
  • Fichtner-Feigl S, Young CA, Kitani A, Geissler EK, Schlitt HJ, Strober W. IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology 135(6), 2003–2013, 2013.e1 (2008).
  • Walker JA, Barlow JL, McKenzie AN. Innate lymphoid cells – how did we miss them? Nat. Rev. Immunol. 13(2), 75–87 (2013).
  • Geremia A, Arancibia-Cárcamo CV, Fleming MP et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J. Exp. Med. 208(6), 1127–1133 (2011).
  • Takayama T, Kamada N, Chinen H et al. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn’s disease. Gastroenterology 139(3), 882–892, 892.e1 (2010).
  • Flier SN, Tanjore H, Kokkotou EG, Sugimoto H, Zeisberg M, Kalluri R. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J. Biol. Chem. 285(26), 20202–20212 (2010).
  • Johnson LA, Rodansky ES, Sauder KL et al. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts. Inflamm. Bowel Dis. 19(5), 891–903 (2013).
  • Johnson LA, Luke A, Sauder K, Moons DS, Horowitz JC, Higgins PD. Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a ‘top-down’ approach to intestinal fibrosis in mice. Inflamm. Bowel Dis. 18(3), 460–471 (2012).
  • Adler J, Rahal K, Swanson SD et al. Anti-tumor necrosis factor a prevents bowel fibrosis assessed by messenger RNA, histology, and magnetization transfer MRI in rats with Crohn’s disease. Inflamm. Bowel Dis. 19(4), 683–690 (2013).
  • Swaminath A, Lichtiger S. Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohn’s colitis. Inflamm. Bowel Dis. 14(2), 213–216 (2008).
  • Manfredi AA, Capobianco A, Bianchi ME, Rovere-Querini P. Regulation of dendritic- and T-cell fate by injury-associated endogenous signals. Crit. Rev. Immunol. 29(1), 69–86 (2009).
  • Gilbert TW, Stewart-Akers AM, Sydeski J, Nguyen TD, Badylak SF, Woo SL. Gene expression by fibroblasts seeded on small intestinal submucosa and subjected to cyclic stretching. Tissue Eng. 13(6), 1313–1323 (2007).
  • Mannon P, Reinisch W. Interleukin 13 and its role in gut defence and inflammation. Gut 61(12), 1765–1773 (2012).
  • Chen YL, Zhang X, Bai J et al. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation. Cell Death Dis. 4, e665 (2013).
  • Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringdén O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57(1), 11–20 (2003).
  • Voswinkel J, Francois S, Simon JM et al. Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review. Clin. Rev. Allergy Immunol. doi:10.1007/s12016-012-8347-6 (2013) (Epub ahead of print).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.